167 related articles for article (PubMed ID: 29749439)
1. High C-X-C motif chemokine 5 expression is associated with malignant phenotypes of prostate cancer cells via autocrine and paracrine pathways.
Qi Y; Zhao W; Li M; Shao M; Wang J; Sui H; Yu H; Shao W; Gui S; Li J; Jia X; Jiang D; Li Y; Zhang P; Wang S; Wang W
Int J Oncol; 2018 Jul; 53(1):358-370. PubMed ID: 29749439
[TBL] [Abstract][Full Text] [Related]
2. Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashion.
Xin H; Cao Y; Shao ML; Zhang W; Zhang CB; Wang JT; Liang LC; Shao WW; Qi YL; Li Y; Zhang ZY; Yang Z; Sun YH; Zhang PX; Jia LL; Wang WQ
Int Urol Nephrol; 2018 May; 50(5):861-868. PubMed ID: 29524043
[TBL] [Abstract][Full Text] [Related]
3. CXCL5 as an autocrine or paracrine cytokine is associated with proliferation and migration of hepatoblastoma HepG2 cells.
Yang Y; Hou J; Shao M; Zhang W; Qi Y; E S; Wang S; Sui H; Meng D; Wang B; Wang M; Han Y; Cao Y; Huang X; Li Y; Zhang P; Wang W
Oncol Lett; 2017 Dec; 14(6):7977-7985. PubMed ID: 29344240
[TBL] [Abstract][Full Text] [Related]
4. CXCL5/ENA78 increased cell migration and epithelial-to-mesenchymal transition of hormone-independent prostate cancer by early growth response-1/snail signaling pathway.
Kuo PL; Chen YH; Chen TC; Shen KH; Hsu YL
J Cell Physiol; 2011 May; 226(5):1224-31. PubMed ID: 20945384
[TBL] [Abstract][Full Text] [Related]
5. CXCL5 promotes the proliferation and migration of glioma cells in autocrine- and paracrine-dependent manners.
Dai Z; Wu J; Chen F; Cheng Q; Zhang M; Wang Y; Guo Y; Song T
Oncol Rep; 2016 Dec; 36(6):3303-3310. PubMed ID: 27748886
[TBL] [Abstract][Full Text] [Related]
6. CXCL5, the upregulated chemokine in patients with uterine cervix cancer, in vivo and in vitro contributes to oncogenic potential of Hela uterine cervix cancer cells.
Feng X; Zhang D; Li X; Ma S; Zhang C; Wang J; Li Y; Liang L; Zhang P; Qu Y; Zhang Z; Yang Z; Xiang Y; Zhang W; Wang S; Shao W; Wang W
Biomed Pharmacother; 2018 Nov; 107():1496-1504. PubMed ID: 30257367
[TBL] [Abstract][Full Text] [Related]
7. Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways.
Zhao J; Ou B; Han D; Wang P; Zong Y; Zhu C; Liu D; Zheng M; Sun J; Feng H; Lu A
Mol Cancer; 2017 Mar; 16(1):70. PubMed ID: 28356111
[TBL] [Abstract][Full Text] [Related]
8. FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-X
Maciel-Silva P; Caldeira I; de Assis Santos I; Carreira ACO; Siqueira FR; Antonioli E; Goldberg AC; Belizário JE; Garay-Malpartida HM
BMC Cancer; 2018 Jan; 18(1):90. PubMed ID: 29357840
[TBL] [Abstract][Full Text] [Related]
9. CXCL3 overexpression promotes the tumorigenic potential of uterine cervical cancer cells via the MAPK/ERK pathway.
Qi YL; Li Y; Man XX; Sui HY; Zhao XL; Zhang PX; Qu XS; Zhang H; Wang BX; Li J; Qi SF; Jia LL; Luan HY; Zhang CB; Wang WQ
J Cell Physiol; 2020 May; 235(5):4756-4765. PubMed ID: 31667838
[TBL] [Abstract][Full Text] [Related]
10. Gα-13 induces C
Lim WK; Chai X; Ghosh S; Ray D; Wang M; Rasheed SAK; Casey PJ
J Biol Chem; 2019 Nov; 294(48):18192-18206. PubMed ID: 31636124
[TBL] [Abstract][Full Text] [Related]
11. Effects of transferred NK4 gene on proliferation, migration, invasion and apoptosis of human prostate cancer DU145 cells.
Yue D; Wang Y; Ma P; Li YY; Chen H; Wang P; Ren CS
Asian J Androl; 2010 May; 12(3):381-9. PubMed ID: 20400971
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
13. CXCL5 Plays a Promoting Role in Osteosarcoma Cell Migration and Invasion in Autocrine- and Paracrine-Dependent Manners.
Dang H; Wu W; Wang B; Cui C; Niu J; Chen J; Chen Z; Liu Y
Oncol Res; 2017 Jan; 25(2):177-186. PubMed ID: 28277189
[TBL] [Abstract][Full Text] [Related]
14. NDRG3 is an androgen regulated and prostate enriched gene that promotes in vitro and in vivo prostate cancer cell growth.
Wang W; Li Y; Li Y; Hong A; Wang J; Lin B; Li R
Int J Cancer; 2009 Feb; 124(3):521-30. PubMed ID: 18975380
[TBL] [Abstract][Full Text] [Related]
15. CXCL5 promotes prostate cancer progression.
Begley LA; Kasina S; Mehra R; Adsule S; Admon AJ; Lonigro RJ; Chinnaiyan AM; Macoska JA
Neoplasia; 2008 Mar; 10(3):244-54. PubMed ID: 18320069
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality.
Sorrentino C; D'Antonio L; Ciummo SL; Fieni C; Landuzzi L; Ruzzi F; Vespa S; Lanuti P; Lotti LV; Lollini PL; Di Carlo E
J Hematol Oncol; 2022 Oct; 15(1):145. PubMed ID: 36224639
[TBL] [Abstract][Full Text] [Related]
17. Activation of CXCL5-CXCR2 axis promotes proliferation and accelerates G1 to S phase transition of papillary thyroid carcinoma cells and activates JNK and p38 pathways.
Cui D; Zhao Y; Xu J
Cancer Biol Ther; 2019; 20(5):608-616. PubMed ID: 30404567
[TBL] [Abstract][Full Text] [Related]
18. Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts.
Okabe H; Beppu T; Ueda M; Hayashi H; Ishiko T; Masuda T; Otao R; Horlad H; Mima K; Miyake K; Iwatsuki M; Baba Y; Takamori H; Jono H; Shinriki S; Ando Y; Baba H
Int J Cancer; 2012 Nov; 131(10):2234-41. PubMed ID: 22337081
[TBL] [Abstract][Full Text] [Related]
19. A S100A14-CCL2/CXCL5 signaling axis drives breast cancer metastasis.
Li X; Wang M; Gong T; Lei X; Hu T; Tian M; Ding F; Ma F; Chen H; Liu Z
Theranostics; 2020; 10(13):5687-5703. PubMed ID: 32483412
[No Abstract] [Full Text] [Related]
20. Expression of Tripartite Motif-Containing Proteactiin 11 (TRIM11) is Associated with the Progression of Human Prostate Cancer and is Downregulated by MicroRNA-5193.
Pan Y; Zhang R; Chen H; Chen W; Wu K; Lv J
Med Sci Monit; 2019 Jan; 25():98-106. PubMed ID: 30608062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
